The ACCP just released new lung cancer screening guidelines.
Patients who develop pulmonary edema after starting prostacyclin for pulmonary arterial hypertension have a greater risk for mortality.
Patients with pulmonary arterial hypertension experienced better improvements in pulmonary arterial compliance with riociguat compared with phosphodiesterase type 5 inhibitors.
Researchers assessed the efficacy of a once-daily treatment option for controlled asthma.
In a retrospective analysis, researchers examined the efficacy of beta blocker therapy in prolonging patients’ lives.
Results indicate that further study of the relationship between the 6-minute walk distance test and functional capacity in PAH is necessary.
A recent study examined whether nebulized glycopyrrolate is safe to use in patients with severe COPD and comorbid cardiovascular risk factors.
The safety of concurrently administering nebulized glycopyrrolate with long-acting beta agonists was examined in 3 studies.
A 3-variable score that encompasses dyspnea score, prednisone use, and prior hospitalization for COPD exacerbations can predict mortality and readmission risk.